RxDoctor Payments DataLook up a doctor →

Michael Seep

Family Medicine · Lake Charles, LANPI 1013993484

Payments from drug & device makers

$9,063,390in general payments, 2019–2025

Across 1,345 payments — averaging $6738.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3.6M
  • AstraZeneca$3.2M
  • AbbVie$1.3M
  • Janssen Research & Development, LLC$563K
  • Sanofi US Services Inc.$112K
  • Pfizer$88K
  • plus $228K from 35 others
$391in research payments, 2019–2025

Across 2 payments — averaging $195.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$391

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron666$3,561,992
AstraZeneca24$3,234,094
AbbVie(2 entities)184$1,276,993
Janssen Research & Development, LLC65$562,516
Sanofi US Services Inc.77$111,868
Pfizer44$87,834
Novo Nordisk AS97$74,195
Kowa Research Institute, Inc.30$46,503
Organon2$30,885
Sage Therapeutics, LLC8$15,299
Bristol Myers Squibb5$14,660
Eli Lilly1$11,600
Novartis9$10,910
Hikma Pharmaceuticals USA1$10,348
GRT US Holding, Inc.4$3,853
Chiesi USA, Inc.1$3,500
Boehringer Ingelheim RCV GmbH & Co KG5$2,610
Lexicon Pharmaceuticals, Inc.2$1,640
Lilly USA, LLC17$243
Bayer10$192
Alnylam Pharmaceuticals Inc.4$182
Amgen20$161
E.r. Squibb & Sons, L.L.C.1$159
Novo Nordisk10$146
Astellas Pharma US Inc8$131
Urovant Sciences Inc1$111
Johnson & Johnson7$102
Merck6$99
Takeda Pharmaceuticals U.S.A., Inc.7$76
Biohaven Pharmaceuticals, Inc.4$74
Mannkind Corporation1$59
Boehringer Ingelheim4$55
Abbott3$54
Amarin Pharma, Inc.4$54
Esperion Therapeutics, Inc.3$41
Sunovion Pharmaceuticals Inc.2$37
Sanofi-aventis U.S. LLC2$27
Kowa Pharmaceuticals America, Inc.2$25
Teva Pharmaceuticals USA, Inc.2$24
Daiichi Sankyo Inc.1$22
Almatica Pharma LLC1$16

How this compares

$9,063,390 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Other family medicine in Lake Charles

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →